Immix Biopharma Inc
(IMMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 2,521 | 3,795 | 1,533 | 1,561 | 1,330 |
| Operating Income | -2,521 | -3,795 | -1,533 | -1,561 | -1,330 |
| Other Income | 28 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -2,493 | -3,795 | -1,533 | -1,561 | -1,330 |
| Income Tax | 5 | 5 | 2 | 2 | 2 |
| Net Income Continuous | -2,498 | -3,800 | -1,535 | -1,563 | -1,332 |
| Minority Interests | -18 | N/A | N/A | N/A | N/A |
| Net Income | $-2,480 | $-3,800 | $-1,535 | $-1,563 | $-1,332 |
| EPS Basic Total Ops | -0.18 | -0.27 | -0.11 | -0.11 | -0.10 |
| EPS Basic Continuous Ops | -0.18 | -0.27 | -0.11 | -0.11 | -0.10 |
| EPS Diluted Total Ops | -0.18 | -0.27 | -0.11 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | -0.18 | -0.27 | -0.11 | -0.11 | -0.10 |
| EBITDA(a) | $-2,520 | $-3,794 | $-1,533 | $-1,561 | $-1,329 |